Amoproxan

CHEMBL2104537 Phase 4 Zugelassen Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
425.5 g/mol
LogP
3.0
Phase
4

A drug with limited current clinical use that has been studied for its effects on the gastrointestinal and cardiovascular systems. Available data on its pharmacology and indications are limited.

Molekularmasse

425,5000 g/mol

LogP

3,00

TPSA

75,70 Ų

Lipinski-Regel der Fünf

Bestanden

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D-Struktur

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

COc1cc(C(=O)OC(COCCC(C)C)CN2CCOCC2)cc(OC)c1OC

InChI

InChI=1S/C22H35NO7/c1-16(2)6-9-29-15-18(14-23-7-10-28-11-8-23)30-22(24)17-12-19(25-3)21(27-5)20(13-17)26-4/h12-13,16,18H,6-11,14-15H2,1-5H3

Molecular Formula

C22H35NO7

HBD / HBA

- / 8

Rotierbare Bindungen

13

Schwere Atome

30

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

A drug with limited current clinical use that has been studied for its effects on the gastrointestinal and cardiovascular systems. Available data on its pharmacology and indications are limited.

Yes, Amoproxan is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2104537. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 31473. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.